c-ANCA-associated vasculitis with predominant CNS demyelination after COVID-19 - 03/01/23
, A. Yahyaoui a, H. Besbes a, b, R.Hadj Salem a, b, S. Zayani a, b, C. Chouchane a, b, S. Chouchane a, b
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Editor: B. Chabrol
Abstract |
COVID-19 infection may trigger the presentation or exacerbation of autoimmune diseases. c-Antineutrophil cytoplasmic antibody (c-ANCA)-associated vasculitis after COVID-19 mainly involves the kidneys and lungs, and is rarely reported. We describe the case of a 13-year-old girl with a history of chronic immunologic thrombocytopenic purpura who presented with transverse myelitis and central nervous system demyelination, and was subsequently diagnosed with c-ANCA-associated vasculitis following COVID-19. The patient's condition improved after pulse therapy with methylprednisolone and rituximab. To our knowledge, this is the first reported pediatric case of ANCA-associated vasculitis with predominant central nervous system involvement after COVID-19 infection.
Le texte complet de cet article est disponible en PDF.Keywords : Vasculitis, ANCA, Myelitis, COVID-19
Plan
Vol 30 - N° 1
P. 74-76 - janvier 2023 Retour au numéro
Article précédent
- Identification of newborns at risk of early-onset neonatal infection: New French guidelines and practices at Nantes University Hospital
- M. Fouminet, S. Barrois, I. Derredinger, L. Baraton, J.C. Roze, C. Boscher, C.Gras Leguen, J.B. Muller
Bienvenue sur EM-consulte, la référence des professionnels de santé.